valproic acid has been researched along with Cacosmia in 3 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Valproic acid (VPA) has been widely used for the treatment of epilepsy." | 3.30 | Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study. ( Hira, D; Kikuoka, H; Matsumoto, K; Ogawa, T; Shimizu, T; Tojima, I, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Ogawa, T | 1 |
| Matsumoto, K | 1 |
| Tojima, I | 1 |
| Kikuoka, H | 1 |
| Hira, D | 1 |
| Shimizu, T | 1 |
| Alvarez, P | 1 |
| Papaseit, E | 1 |
| Pérez, V | 1 |
| Bulbena, A | 1 |
| Farré, M | 1 |
| Castro, AA | 1 |
| Ghisoni, K | 1 |
| Latini, A | 1 |
| Quevedo, J | 1 |
| Tasca, CI | 1 |
| Prediger, RD | 1 |
1 trial available for valproic acid and Cacosmia
| Article | Year |
|---|---|
Therapeutic Potential of Valproic Acid for Postviral Olfactory Dysfunction: A Single-Arm Pilot Study.
Topics: Animals; Anosmia; Olfaction Disorders; Pilot Projects; Smell; Valproic Acid | 2023 |
2 other studies available for valproic acid and Cacosmia
| Article | Year |
|---|---|
Reversible taste and smell dysfunction associated with sodium valproate and quetiapine in bipolar depression: a case report.
Topics: Antimanic Agents; Antipsychotic Agents; Bipolar Disorder; Drug Therapy, Combination; Humans; Male; M | 2019 |
Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Administration, Intranasal; Age Factors; Animals; Anim | 2012 |